Lipella Pharmaceuticals Inc. (LIPO) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q1'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 173.67K | 0 | 0 | 0 | 449.62K | 104.05K | 0 | 0 | 151.01K | 0 | 0 | 33.15K | 25.88K | 84.5K |
| Revenue Growth % | - | - | - | -61.37% | -100% | - | - | 197.75% | - | - | -100% | 483.47% | - | - | - | - | - |
| Cost of Goods Sold | 720.97K | 791.58K | 993.48K | 1.06M | 1.05M | 661.56K | 842.6K | 454.2K | 833.26K | 1.06M | 693.73K | 478.1K | 650.95K | 742.66K | 675.96K | 373.4K | 258.33K |
| COGS % of Revenue | - | - | - | 611.71% | - | - | - | 101.02% | 800.82% | - | - | 316.61% | - | - | 2039.16% | 1442.75% | 305.72% |
| Gross Profit | -720.97K | -791.58K | -993.48K | -888.67K | -1.05M | -661.56K | -842.6K | -4.58K | -729.21K | -1.06M | -693.73K | -327.1K | -650.95K | -742.66K | -642.81K | -347.52K | -173.83K |
| Gross Margin % | - | - | - | -511.71% | - | - | - | -1.02% | -700.82% | - | - | -216.61% | - | - | -1939.16% | -1342.75% | -205.72% |
| Gross Profit Growth % | 31.12% | -19.65% | -17.91% | -19290.57% | -43.54% | 37.45% | -21.46% | 98.6% | -12.02% | -42.41% | -7.92% | 5.88% | - | - | - | - | - |
| Operating Expenses | 553.3K | 564.99K | 334.35K | 562.62K | 412.72K | 290.63K | 375.05K | 725.01K | 627.52K | 517.55K | 390.7K | 32.17K | 61.69K | 38.49K | 93.85K | 92.64K | 439.07K |
| OpEx % of Revenue | - | - | - | 323.97% | - | - | - | 161.25% | 603.09% | - | - | 21.3% | - | - | 283.12% | 357.97% | 519.62% |
| Selling, General & Admin | 553.3K | 651.72K | 463.74K | 562.62K | 493.1K | 427.06K | 520.93K | 396.24K | 627.52K | 624.23K | 508.75K | 32.17K | 61.69K | 38.49K | 93.85K | 92.64K | 439.07K |
| SG&A % of Revenue | - | - | - | 323.97% | - | - | - | 88.13% | 603.09% | - | - | 21.3% | - | - | 283.12% | 357.97% | 519.62% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.06M | 693.73K | 478.1K | 665.02K | 742.66K | 675.96K | 373.4K | 258.33K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | 316.61% | - | - | 2039.16% | 1442.75% | 305.72% |
| Other Operating Expenses | 0 | -86.73K | -129.39K | 0 | -80.38K | -136.43K | -145.88K | 328.77K | 0 | -1000K | -811.78K | -478.1K | -665.02K | -742.66K | -675.96K | -373.4K | -258.33K |
| Operating Income | -1.27M | -1.36M | -1.33M | -1.45M | -1.46M | -952.19K | -1.22M | -729.59K | -1.36M | -1.58M | -1.08M | -359.26K | -712.64K | -781.15K | -736.66K | -440.16K | -612.9K |
| Operating Margin % | - | - | - | -835.68% | - | - | - | -162.27% | -1303.91% | - | - | -237.91% | - | - | -2222.28% | -1700.71% | -725.34% |
| Operating Income Growth % | 12.69% | -42.47% | -9.05% | -98.92% | -7.57% | 39.55% | -12.28% | -103.08% | -90.38% | -101.65% | -47.21% | 18.38% | - | - | - | - | - |
| EBITDA | -1.27M | -1.36M | -1.33M | -1.45M | -1.46M | -951.47K | -1.22M | -728.87K | -1.36M | -1.53M | -1.06M | -359.22K | -712.14K | -780.39K | -736.33K | -382.98K | -612.9K |
| EBITDA Margin % | - | - | - | -835.26% | - | - | - | -162.11% | -1302.98% | - | - | -237.88% | - | - | -2221.28% | -1479.76% | -725.34% |
| EBITDA Growth % | 12.69% | -42.5% | -9.05% | -99.02% | -7.59% | 37.94% | -14.54% | -102.9% | -90.38% | -96.47% | -44.29% | 6.2% | - | - | - | - | - |
| D&A (Non-Cash Add-back) | 722 | 721 | 722 | 721 | 722 | 722 | 721 | 723 | 962 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -1.25M | -1.33M | -1.31M | -1.44M | -1.44M | -938.15K | -1.19M | -688.88K | -1.32M | -1.53M | -1.06M | -359.22K | -712.14K | -780.39K | -736.33K | -382.98K | -612.9K |
| Net Interest Income | 20.19K | 29.09K | 21.3K | 9.62K | 14.78K | 14.04K | 25.84K | 40.71K | 33.16K | 36.51K | 16.61K | -4.66K | -1.15K | -1.03K | -1.09K | -1.61K | -1.7K |
| Interest Income | 20.19K | 29.09K | 21.3K | 9.62K | 14.78K | 14.04K | 25.84K | 40.71K | 33.16K | 41.97K | 22K | 42 | 501 | 604 | 531 | 101 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.45K | 5.39K | 4.7K | 1.65K | 1.64K | 1.62K | 1.71K | 1.7K |
| Other Income/Expense | 20.19K | 29.09K | 21.3K | 9.62K | 14.78K | 14.04K | 25.84K | 40.71K | 33.16K | 36.51K | 16.61K | -4.66K | -1.15K | -877 | -1.29K | 55.47K | -1.7K |
| Pretax Income | -1.25M | -1.33M | -1.31M | -1.44M | -1.44M | -938.15K | -1.19M | -688.88K | -1.32M | -1.54M | -1.07M | -363.93K | -713.79K | -782.02K | -737.95K | -384.69K | -614.6K |
| Pretax Margin % | - | - | - | -830.14% | - | - | - | -153.22% | -1272.04% | - | - | -241% | - | - | -2226.16% | -1486.38% | -727.35% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -1.25M | -1.33M | -1.31M | -1.44M | -1.44M | -938.15K | -1.19M | -688.88K | -1.32M | -1.54M | -1.07M | -363.93K | -713.79K | -782.02K | -737.95K | -384.69K | -614.6K |
| Net Margin % | - | - | - | -830.14% | - | - | - | -153.22% | -1272.04% | - | - | -241% | - | - | -2226.16% | -1486.38% | -727.35% |
| Net Income Growth % | 13.19% | -41.5% | -9.63% | -109.28% | -9.15% | 39.03% | -11.61% | -89.29% | -85.43% | -96.76% | -44.7% | 5.4% | - | - | - | - | - |
| Net Income (Continuing) | -1.25M | -1.33M | -1.31M | -1.44M | -1.44M | -938.15K | -1.19M | -688.88K | -1.32M | -1.54M | -1.07M | -363.93K | -713.79K | -782.02K | -737.95K | -384.69K | -614.6K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.28 | -0.31 | -0.64 | -1.37 | -1.29 | -0.99 | -1.31 | -0.84 | -1.84 | -2.16 | -1.52 | -0.66 | -1.39 | -1.62 | -1.53 | -0.85 | -2.00 |
| EPS Growth % | 78.29% | 68.69% | 51.14% | -63.1% | 29.89% | 54.17% | 13.82% | -27.27% | -32.37% | -33.33% | 0.65% | 22.35% | - | - | - | - | - |
| EPS (Basic) | -0.28 | -0.31 | -0.64 | -1.37 | -1.29 | -0.99 | -1.31 | -0.81 | -1.84 | -2.14 | -1.49 | -0.66 | -1.39 | -1.62 | -1.53 | -0.79 | -1.95 |
| Diluted Shares Outstanding | 4.55M | 4.31M | 1.05M | 1.05M | 1.12M | 950.71K | 911.55K | 846.32K | 719.22K | 717.99K | 717.99K | 550.1K | 513.23K | 483.33K | 483.33K | 483.96K | 315.59K |
| Basic Shares Outstanding | 4.55M | 4.31M | 1.05M | 1.05M | 1.12M | 950.71K | 911.55K | 816.27K | 719.22K | 712.35K | 702.52K | 550.1K | 513.23K | 483.33K | 483.33K | 453.7K | 307.3K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |